Rick Mullin

发表

Rick Mullin, 2014 .

Community outreach 35 years after Bhopal

Rick Mullin, 2019 .

LILLY SETS OUT TO REORGANIZE: PHARMACEUTICALS: Plan will establish five business units and cut $1 billion in costs, 5,500 jobs

Rick Mullin, 2009 .

THINKING SMALL: Under NEW LEADERSHIP, SOCMA broadens its trawl for batch manufacturers

Rick Mullin, 2010 .

Nemus and Noramco join for cannabinoid

Rick Mullin, 2019 .

THE NEW COMPUTING PIONEERS

Rick Mullin, 2009 .

A Mercury Chelator

Rick Mullin, 2015 .

Johns Hopkins research gets venture backing

Rick Mullin, 2017 .

PHARMACEUTICALS Eyeing new market, Novartis will invest $500 million in Russia

Rick Mullin, 2011 .

Chiral Technologies acquires oligos firm

Rick Mullin, 2019 .

High-end innovation leads textile dyes

Rick Mullin, 2004 .

BIOPHARMACEUTICALS: 'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs

Rick Mullin, 2004 .

Partnership applies deep learning to very big data

Rick Mullin, 2017 .

PFIZER TAPS INCYTE FOR COMPOUNDS: Drug giant advances a strategy of supplementing its internal pipeline

Rick Mullin, 2005 .

INFORMATION TECHNOLOGY: With the advent of Internet-based system architectures, chemical producers get ready to plug and play

Rick Mullin, 2006 .

GSK APPLAUDS U.K. TAX BREAKS: PHARMACEUTICALS: Firm pins investments to a tax break on intellectual-property-generated profits

Rick Mullin, 2010 .

INNOVATION ENGINE: Merck sees PIPELINE STRENGTH getting it through a challenging 2012

Rick Mullin, 2011 .

BASF taps Citrine for artificial intelligence

Rick Mullin, 2018 .

Incyte buys Ariad’s European operations

Rick Mullin, 2016 .

PERIPHERAL ADVANCES: Chemical companies are experimenting with cuttingedge add-ons to their INFORMATION TECHNOLOGY hubs

Rick Mullin, 2011 .

Army Corps suspends permit on Formosa plant

Rick Mullin, 2020 .

Johnson Matthey teams with Intrexon

Rick Mullin, 2017 .

Atomwise signs with Bridge Biotherapeutic

Rick Mullin, 2020 .

Suppliers to the drug industry are trying to stay ahead of competitors, customers, and technologies.

Rick Mullin, Bill Schmitt, Scott Morrison, 2002 .

A suspenseful ACT II for Rohner

Rick Mullin, 2003 .

Eastman re-ups university R&D pacts

Rick Mullin, 2019 .

THE NEXT GENERATION IN GENOME SEQUENCING

Rick Mullin, 2011 .

BMS teams with Grail on cancer detection

Rick Mullin, 2017 .

THE BIG PICTURE: Drug firms forge an information management architecture to take on the RESEARCH DATA GLUT

Rick Mullin, 2007 .

THE ALLURE OF THE GARDEN STATE: Overseas fine chemicals companies are taking New Jersey seriously

Rick Mullin, 2005 .

TARGET PRACTICE: Software and database vendors aim to supply researchers with tools to extract QUALITY FROM QUANTITY

Rick Mullin, 2007 .

EUROPE REBOUNDS: CHEMSPEC showcases a revitalized contract manufacturing sector and a growing role for private capital

Rick Mullin, 2007 .

THE THIRD WAVE: Aspen Technology offers process modeling as the antidote to information overload

Rick Mullin, 2002 .

Merck will boost production in Ireland

Rick Mullin, 2017 .

Opportunity in the turmoil

Rick Mullin, 2018 .

THE PARTNERSHIP PUSH: The value of alliances between drug majors and biotechnology firms has shot up, with a renewed interest in early-stage deals

Rick Mullin, 2006 .

SHOCK TO THE SYSTEM: Big questions about DRUG SAFETY arise in the wake of rampant supply-chain globalization

Rick Mullin, 2011 .

INCREASED WINGSPAN: Key players in the specialties sector claim they have evolved through adversity, adapting for success in emerging growth markets

Patricia Short, Rick Mullin, Alex Tullo, 2004 .

Basic materials keep a technology edge

Rick Mullin, 2002 .

Axyntis, PMC vie to buy Isochem

Rick Mullin, 2017 .

Roche adds data firm to diagnostics arm

Rick Mullin, 2017 .

Drug service provider Alcami changes hands

Rick Mullin, 2018 .

Up From Chaos

Rick Mullin, 2013 .

FINE CHEMICALS FIRMS CONTINUE TO EXPAND: At INFORMEX, companies touted investments in facilities and technology

Ann Thayer, Rick Mullin, 2009 .

Drugmakers connect with Gates Foundation

Rick Mullin, 2020 .

Boehringer invests in tableting plant

Rick Mullin, 2018 .

Lonza adds gene-editing service

Rick Mullin, 2019 .

Dottikon set to boost drug ingredient output

Rick Mullin, 2020 .

Cambrex expanding generics R&D in Italy

Rick Mullin, 2018 .

ROCHE, DSM INK DOWNSIZED DEAL: Swiss firm sheds vitamins business, bolsters diagnostics with acquisition

Rick Mullin, 2003 .

Ups and downs for Pfizer in contract manufacturing

Rick Mullin, 2017 .

BATTENING THE HATCHES: Sailing toward the long-dreaded ‘PATENT CLIFF,’ drug firms positioned themselves for a new world of science and business in 2010

Rick Mullin, 2010 .

FRUSTRATION, HOPE AT BIOTECH EVENT: BIO 2007: Speakers point to struggle of getting drugs from lab to patients

Rick Mullin, 2007 .

CYBER SECURITY Software firm identifies hacking program against chemical makers

Rick Mullin, 2011 .

KEEPING TRACK: LABORATORY MANAGEMENT SOFTWARE takes on the data explosion in life sciences

Rick Mullin, 2008 .

STA adds to drug service offerings

Rick Mullin, 2017 .

AMRI confronts change, again

Rick Mullin, 2017 .

A SENSE OF URGENCY: Call for DRUG SAFETY pushes the mundane art of supply chain management to the front burner

Rick Mullin, 2011 .

Service providers move upstream

Rick Mullin, R. Mullin, 2003 .

Software targets animal testing

Rick Mullin, 2017 .

EUTICALS MAKES ITS GLOBAL MOVE: The small Italian pharma chemicals firm HARNESSES ARCHIMICA

Rick Mullin, 2011 .

Pharma: Fine chemical firms reposition

Rick Mullin, Natasha Alperowicz, 2002 .

Patheon to expand

Rick Mullin, 2017 .

DRUG DISCOVERY: Pure science yields to applied science as the genomics revolution focuses its energy on commercialization

Rick Mullin, 2003 .

DEALING WITH DATA OVERLOAD: Analysis and routing strategies emerge as the chemical industry focuses on what information it needs rather than how much is generated

Rick Mullin, 2004 .

Fresenius pushes further into generics

Rick Mullin, 2017 .

A Virtue Of Chaos

Rick Mullin, 2015 .

Ibuprofen shortage causes headache for analgesic makers

Rick Mullin, 2018 .

Partnership doles out funds for antibacterials

Rick Mullin, 2017 .

Almac hikes peptides and continuous flow

Rick Mullin, 2019 .

The Human Element

Rick Mullin, 2015 .

CPHI SHOWCASES TRANSFORMATION: Refocused producers bring new plays to the tough game of pharmaceutical contract manufacturing

Rick Mullin, 2004 .

Investment booms in AI for drug research

Rick Mullin, 2019 .

C&EN TALKS WITH: WALLY GILBERTA biotechnology pioneer takes on the big picture

Rick Mullin, 2006 .

DRUG DISCOVERY PERSPECTIVES: Technology, finance, and regulatory support back a Herculean endeavor

Rick Mullin, 2003 .

Renewed Strength For Sector At Year's End

Rick Mullin, 2002 .

DRUGS FOR THE POOR

Rick Mullin, 2005 .

BIOTECH FIRMS SEE NEW-DRUG UPSWING: Attendees at BIO 2005 conference are bullish on technology's potential

Rick Mullin, 2005 .

Contract services evolve

Rick Mullin, 2017 .

Piramal invests in drug actives

Rick Mullin, 2017 .

SIGMA-ALDRICH'S NEW FIVE-YEAR PLAN: The firm's SAFC fine chemicals group has set itself apart and is in position for growth

Rick Mullin, 2006 .

INSIGHTS: FUTURE DOCBig questions and ethical conundrums abound at the dawn of'personalized medicine'

Rick Mullin, 2006 .

MAKING THE NEXT MOVE: Chemical industry CIOs defend their role as strategists in the post-cost-cutting era

Rick Mullin, 2004 .

Wake-Up Call

Rick Mullin, 2014 .

NEWS OF THE WEEK: CELEBREX FIGHTConsumer group says 1999 study of Pfizer's drug reveals heart hazards

Rick Mullin, 2005 .

PHARMACEUTICALS Merck will cut jobs in revamp of former Schering-Plough headquarters

Rick Mullin, 2011 .

News: With the drug industry pressed to find new paths to innovation, the tension between large- and small-molecule therapeutics takes center stage

Rick Mullin, 2003 .

Flux In French Fine Chemicals

Rick Mullin, 2013 .

GSK invests in APIs in Scotland

Rick Mullin, 2018 .

Zapata raises funds for quantum computing

Rick Mullin, 2019 .

Cambrex opens new labs in Karlskoga

Rick Mullin, 2019 .

BEFORE THE STORM: A near record high in NEW DRUG APPROVALS fortifies the pharmaceutical industry ahead of next year’s patent expiries

Rick Mullin, 2011 .

Axyntis boosts output at French plant

Rick Mullin, 2018 .

Evonik offloads Kansas agchem plant

Rick Mullin, 2018 .

REVIVING AN OLD DRUG: Critical Therapeutics relaunches an asthma drug with the help of Rhodia manufacturing

Rick Mullin, 2005 .

EXELIXIS AFTER GSK: A six-year partnership ends, and a new era begins for a BIOTECHNOLOGY PIONEER

Rick Mullin, R. Mullin, 2009 .

Flamma starts digging on R&D boost

Rick Mullin, 2020 .

MATERIALS ENGINEERING GE taps Detroit-area talent for a new manufacturing R&D center

Rick Mullin, 2009 .

FDA will vet Emulate’s organ chip

Rick Mullin, 2017 .

Famar buys Bayer plant in Quebec

Rick Mullin, 2017 .

AstraZeneca Drug Delay Hits Avecia

Rick Mullin, 2002 .

Avara pulls back from pharmaceutical chemicals

Rick Mullin, 2019 .

TUFTS REPORT ANTICIPATES UPTURN: Cites drugmakers' actions to accelerate drug development

Rick Mullin, 2006 .

Rise of the smartish machines

Rick Mullin, 2018 .

SPECIALTIES BOUNCE: Micro X tennis ball is a LITTLE AMBASSADOR for a transformed Akzo Nobel

Rick Mullin, 2008 .

INDUSTRIAL BIOTECH AT THE BOTTOM LINE: Green technology agenda shifts to the other green stuff—dollars

Rick Mullin, 2004 .

DRUG COMPANIES TAKE CONTROL: Industry is pushed toward PROCESS MANAGEMENT regimes mat link drug development to product launch

Rick Mullin, 2007 .

Gene therapy firms issue ethics guide

Rick Mullin, 2019 .

SPECIALTIES REVIVAL: ChemSpec exhibitors shape up services, push performance chemicals

Rick Mullin, 2004 .

PATENT ANXIETY: GlaxoSmithKline’s move against changes at the Patent Office highlights a perceived THREAT TO DRUG RESEARCH

Rick Mullin, 2007 .

Let’s talk about quantum computing in drug discovery

Rick Mullin, 2020 .

Allergan consolidates in New Jersey

Rick Mullin, 2016 .

Building pharmaceutical outsourcing partnerships

Ann Thayer, Rick Mullin, Michael Mccoy, 2017 .

AGC taps Citrine for AI in materials discovery

Rick Mullin, 2020 .

SOCMA Opts Out Of Responsible Care

Rick Mullin, 2005 .

PHARMACEUTICALS Novartis and MIT to research continuous manufacturing

Rick Mullin, 2007 .

Taking Big Data To The Bench

Rick Mullin, 2015 .

FDA RECONSIDERS ELECTRONIC FILING: Agency's review of data filing rule is being watched by drug and other industries

Rick Mullin, 2003 .

THE UPS AND DOWNS OF A ONE-STOP SHOP: AMRI hopes to rebound following setbacks in its PHARMA SERVICES EXPANSION in 2010

Rick Mullin, 2010 .

Few follow dupont in outsourcing: Chemical companies lag other industries in handing off IT services

Rick Mullin, 2002 .

C& EN TALKS WITH: AGNES VARISA champion for the generic drug industry deftly mixes business and Democratic politics

Rick Mullin, 2005 .

QUESTIONED DEALS IN EUROPE: PHARMACEUTICALS: European Commission seeks to vet settlements for payoffs to generic drugmakers

Rick Mullin, 2010 .

Generic Pharmacia Drug For Poor Nations

Rick Mullin, 2003 .

INFORMEX INFORMS: Custom chemical trade show heralds new directions for industry

Rick Mullin, 2005 .

A Spanish David With Goliath Plans

Rick Mullin, 2013 .

France’s Novacap acquires again

Rick Mullin, 2017 .

DOW WILL BUY ROHM AND HAAS: CHEMICAL GIANT: Dow’s move would create the world’s largest specialties and advanced materials company

Rick Mullin, 2008 .

RESEARCH AT THE HERETICAL EDGE: JOHNSON & JOHNSON shares a cloud-hosted data management system with its brethren in big pharma

Rick Mullin, 2011 .

CELGENE TO BUY PARTNER PHARMION: ACQUISITION: $2.9 billion purchase will strengthen Celgene’s oncology pipeline

Rick Mullin, 2007 .

TECHNOLOGY TRANSFER: Report claims universities' focus on revenue generation in licensing STIFLES INNOVATION

Rick Mullin, 2007 .

Emulate advances its organ emulation chip

Rick Mullin, 2016 .

Altivia to buy Dow’s Institute plant

Rick Mullin, 2019 .

REWIRING RESEARCH AT PFIZER: Top executives are charged with streamlining an R&D behemoth as they build a BIOPHARMA JUGGERNAUT

Rick Mullin, 2008 .

End To End

Rick Mullin, Rick Mullin, 2015 .

STIFF UPPER LIP IN MANCHESTER: Specialty and fine chemicals companies at ChemSpec push forward through the slump

Rick Mullin, 2003 .

LIMS IN THE CLOUD: Laboratory information management system software for SMALL USERS makes maximum use of the Internet

Rick Mullin, 2010 .

VANISHING BOOKS: With the advent of DIGITAL INFORMATION, traditional corporate libraries are shrinking or disappearing entirely

Rick Mullin, 2008 .

Schering-Plough Sees 'Turnaround' After Rough Patch

Rick Mullin, 2005 .

Pfizer To Expand In Manhattan, New Jersey

Rick Mullin, 2003 .

DRUGMAKER PARTNERSHIPS: Agreements involving Lilly and Roche seen as part of an upward trend

Rick Mullin, 2002 .

Paul Turgeon taking the helm at MFG

Rick Mullin, 2020 .

DOW CORNING PLUGS INTO ELECTRONICS

Rick Mullin, 2003 .

Sigma-Aldrich: Building a high-tech platform

Rick Mullin, 2002 .

BIOPHARMACEUTICALS Gates Foundation funds Liquidia’s vaccine development program

Rick Mullin, 2011 .

C&EN talks with Jennifer Abril, the new head of SOCMA

Rick Mullin, 2018 .

DIGITAL CONNECTIONS: Boston IT trade shows include SAP user meeting and biotech expo

Rick Mullin, 2005 .

IMPROVING PROFITABILITY: Newly independent from Total, Arkema pushes to boost performance, raise profits

Rick Mullin, 2006 .

Thermo Fisher to double viral vectors

Rick Mullin, 2020 .

Gilead to acquire Kite Pharma for $11.9 billion

Rick Mullin, 2017 .

NOVARTIS ACTS TO ACQUIRE ALCON: PHARMACEUTICALS: Deal will make Swiss giant a big player in eye care

Rick Mullin, 2010 .

C&EN TALKS WITH: RUDOLF HANKOBayer's head of fine chemicals puts technology in a service context

Rick Mullin, 2003 .

Tripos To Host Research Fellows In England

Rick Mullin, 2005 .

RESURRECTION ON THE RHINE: A downsized ROHNER gets another crack at contract manufacturing

Rick Mullin, 2010 .

Rethinking industrial analytical chemistry

Rick Mullin, 2017 .

Drugmakers Join To Study A Viral Threat

Rick Mullin, 2013 .

Merck KGaA grabs Grzybowski Scientific

Rick Mullin, 2017 .

Lonza nabs U.S. biologics site

Rick Mullin, 2017 .

Avantor buys high-purity chemical supplier

Rick Mullin, 2017 .

Small molecules hold sway at DCAT Week

Rick Mullin, 2019 .

Drug R&D Costs Take Big Leap

Rick Mullin, R. Mullin, 2015 .

PHARMACEUTICALS Sanofi will buy Chattem, targeting U.S.’s over-the-counter market

Rick Mullin, 2010 .

INFORMEX LOOKS AT EARLY PIPELINE: Kilogram-scale production and biocatalysis are sunny spots on the custom landscape

Rick Mullin, Michael Mccoy, 2004 .

AIDS Drug To Net $525 Million For Emory University

Rick Mullin, 2005 .

No end in sight for drug services growth

Rick Mullin, 2019 .

PFIZER EXPANDS R&D NETWORK: PARTNERSHIP: Eight Boston research institutions will form a third regional hub

Rick Mullin, 2011 .

Deals Energize Drug Conference

Rick Mullin, 2013 .

INSIGHTS: GIVE PEACE A CHANCEA call for time-out in the war over technology

Rick Mullin, 2005 .

AEROJET HITS ITS MARK: Reengineered fine chemicals unit profits from a chiral separations and hazardous chemistry focus

Rick Mullin, 2003 .

Continuus Pharma wins new funding

Rick Mullin, 2019 .

GSK PAYS BIG: PHARMACEUTICALS: Settlement for $750 million reflects U.S. crackdown on adulterated products

Rick Mullin, 2010 .

SNPE PULLS OUT OF TEXAS VENTURE: Toulouse phosgene edict halts a big push into the U.S. market

Rick Mullin, 2002 .

PHARMA RESEARCH Pfizer will eliminate up to 800 R&D positions in 2009

Rick Mullin, 2009 .

A familiar voice in the lab

Rick Mullin, 2019 .

RHODIA WILL EXIT CUSTOM SYNTHESIS: India's Shasun Chemicals will acquire former ChiRex business

Rick Mullin, 2006 .

The drug industry’s data integrity problem

Rick Mullin, 2018 .

BIOTECHNOLOGY'S CAPITAL SPIN: Industry conference puts biotech in a national policy framework

Rick Mullin, 2003 .

STREAMLINING UTAH'S POPULATION DATABASE: LineaGen, a University of Utah spin-off, teams with IBM to make a lineage record trove more navigable

Rick Mullin, 2005 .

Pharmaceuticals: AstraZeneca, Amgen join to advance monoclonal antibodies

Rick Mullin, 2013 .

Group targets a platform for collaborative data management in drug discovery

Rick Mullin, 2019 .

Big data, big deadlines spur change in tox testing

Rick Mullin, 2017 .

Redefining the endgame

Rick Mullin, 2003 .

BATTENING THE HATCHES

Rick Mullin, 2010 .

Pfizer outbids competitors for Medivation

Rick Mullin, 2016 .

DRUG AVAILABILITY: EU sets plan to make pharmaceuticals available to poor countries

Rick Mullin, 2003 .

Online R&D provider raises more funds

Rick Mullin, 2017 .

INSIGHTS: FRANKENSTEIN AT THE CIRCUSWhat glory would attend the discovery,if I could bannish diease from and render man invulnerable to any but a violent death!

Rick Mullin, 2006 .

PAYING ATTENTION TO MANUFACTURING: Consortia aim to BRIDGE THE GAP between drug development and manufacturing with a technology and engineering focus

Rick Mullin, 2011 .

Firms team up for sublingual drug delivery

Rick Mullin, 2019 .

KLAUS ENGEL: New DEGUSSA CHAIRMAN is hunting for growth opportunities

Rick Mullin, 2007 .

REP RESILIENCE: cleave to traditional codes in a sea of change cleave to traditional codes in a sea of change

Rick Mullin, 2005 .

Life Sciences Come To Life In New York

Rick Mullin, 2015 .

Mussels, potatoes, ‘Anne of Green Gables,’ and now biologics

Rick Mullin, 2018 .

Ardena acquires drug substance firm

Rick Mullin, 2018 .

AMRI, Thermo Fisher ink vaccine deals

Rick Mullin, 2020 .

JAPAN OFFERS EBOLA TRIAL DRUG

Rick Mullin, 2015 .

Capacity keeps climbing to fill projected shortfall

Rick Mullin, 2002 .

POLICING THE PHARMA SUPPLY CHAIN: Drugmakers and regulators are struggling to secure a market that relies heavily on OUTSOURCING

Rick Mullin, 2010 .

BIG PHARMA COMES TO TOWN: When in Cambridge, major drug companies play by Cambridge rules in a QUEST FOR BREAKTHROUGHS

Rick Mullin, 2010 .

DRUG DISCOVERY: As high-throughput screening draws fire, researchers leverage science to put automation into perspective

Rick Mullin, R. Mullin, 2004 .

And now: The drug plant of the future

Rick Mullin, 2017 .

The new ID of a reborn plan

Rick Mullin, Alex Scott, Stephen Moore, 2002 .

Watson shifts from drug discovery to the clinic

Rick Mullin, 2019 .

RESET FOR FINE CHEMICALS: Attendees at the annual CHEMSPEC EUROPE exhibition calibrated growth prospects in recuperating markets

Rick Mullin, R. Mullin, 2011 .

Wacker acquires fermentation firm

Rick Mullin, 2018 .

SOCMA REENGINEERS ITS ANNUAL MEETING: Custom and batch chemical producers put off tee time in a tough business environment

Rick Mullin, 2003 .

SANOFI, GENZYME COME TO TERMS: ACQUISITIONS: For $20 billion, French firm nets a biologics pipeline

Rick Mullin, 2011 .

Cambrex will up capacity at Iowa facility

Rick Mullin, 2020 .

Drug chemical makers brace as China cracks down

Rick Mullin, 2018 .

Hovione bulks up, with a twist

Rick Mullin, 2018 .

C&EN talks with Jeff Flake, former Republican senator and a critic of President Trump

Rick Mullin, 2019 .

A Vibrant Sector Shines In Madrid

Rick Mullin, 2016 .

PFIZER REVEALS PLANT CLOSURES: DOWNSIZING: Five-year plan will eliminate 6,000 jobs worldwide

Rick Mullin, 2010 .

DRUGMAKERS BOND ON SUPPLY SAFETY: RX-360, a consortium of pharmaceutical companies and their suppliers, hopes to foster shared audits

Rick Mullin, 2009 .

STIMULUS PROGRAM UNDERWHELMS: SMALL PHARMA FIRMS cite government’s glaring underestimation of the response to a $1 billion program

Rick Mullin, 2011 .

Pharma business: Biotech and pharmaceutical industries wrestle with large- versus small-molecule drug strategies while financial performance declines

Ann Thayer, Rick Mullin, 2003 .

CAMBREX GETS DOWN TO FIGHTING WEIGHT: Fine chemicals pioneer hopes to rebound with a tighter focus on human health

Rick Mullin, 2004 .

DO-OR-DIE TIME: R&D chiefs agree that big pharma’s FULLY INTEGRATED BUSINESS MODEL has one more chance to deliver

Rick Mullin, 2011 .

BENCHTOP INFORMATICS: ACCELRYS is pushing to expand its market with electronic laboratory notebooks

Rick Mullin, 2011 .

ENTERPRISE SOFTWARE IN THE ANNUS HORRIBILIS

Rick Mullin, 2009 .

TRANSFORMING SIEGFRIED: Newcomer CEO RUDOLF HANKO looks at two businesses and sees one

Rick Mullin, 2010 .

DELIVERING RNA: CASE STUDY #2: Two firms partner to make the active ingredient and a delivery component of a cancer therapy

Rick Mullin, 2007 .

PHARMA SECTOR PONDERS RECESSION: Contract manufacturers at CPhI see constraints and opportunities in a difficult market

Lisa Jarvis, Rick Mullin, 2008 .

Switzerland’s hidden hub

Rick Mullin, 2016 .

Novartis advances new malaria drug

Rick Mullin, 2017 .

BioVectra ramps up cannabidiol output

Rick Mullin, 2019 .

THE SCIENCE SCENE IN GREENWICH VILLAGE

Rick Mullin, 2003 .

RIDING THE WAVE: Chemical producers are pushing IT architecture into a Web-based world of business computing

Rick Mullin, 2002 .

STEM CELLS Pfizer coordinates its regenerative medicine research efforts

Rick Mullin, 2008 .

PHARMA COMMUNITY LOOKS TO IMPROVE: Annual DDT conference addresses inefficiencies in launching new drugs

Rick Mullin, 2005 .

Pfizer will end neuroscience R&D

Rick Mullin, 2018 .

RHODIA CONSOLIDATES IN THE GARDEN STATE: Move into new facilities in New Jersey is part of larger revamping in pharmaceutical chemicals

Rick Mullin, 2004 .

Synthetic chemistry moves into concrete

Rick Mullin, 2004 .

STATESIDE SURGE IN PHARMA CHEMICALS: Investment flows into the U.S. as drugmakers REASSESS their supply chains

Rick Mullin, 2009 .

LEADING CLARIANT BEYOND THE CRISIS: New CEO HARIOLF KOTTMANN seeks to complete a long restructuring at the Swiss specialties firm

Rick Mullin, 2009 .

CORN CHEMISTRY: DuPont lands big government grant, comes close to new route to fiber

Rick Mullin, 2002 .

PREFERRED CONTRACTS: Custom manufacturers of pharmaceutical actives and intermediates VIE FOR A POSITION in new big pharma supply chains

Rick Mullin, 2008 .

Accelrys makes a play for the lab

Rick Mullin, 2003 .

Behind the scenes at the STEM-humanities culture war

Rick Mullin, 2019 .

Grace signs deal for fluorine chemistry

Rick Mullin, 2017 .

Lonza is picked for cannabinoid synthesis

Rick Mullin, 2019 .

INSIGHTS: STICKS IN THE MUDA trip to the corner office reveals the link between cave drawings and chemistry

Rick Mullin, 2004 .

NEW BEARINGS IN FINE CHEMICALS

Rick Mullin, 2005 .

Quantum computer IonQ raises funds

Rick Mullin, 2019 .

Beyond The Patent Cliff

Rick Mullin, R. Mullin, 2013 .

MPD acquires custom firm Norquay

Rick Mullin, 2018 .

VWR strikes twice for clinical services

Rick Mullin, 2017 .

Innovative growth: Just one word : 'textronics'

Rick Mullin, 2002 .

Come Together: A funding initiative for CANCER RESEARCH taps into a game-shifting trend toward collaboration

Rick Mullin, 2008 .

AMGEN, TAKEDA INK BIG LICENSING DEAL: PHARMACEUTICALS: $1 billion pact gives Takeda dibs on 13 molecules in Japan

Rick Mullin, 2008 .

SHIFTING TO SERVICES: Attendees at CHEMSPEC EUROPE in Berlin see opportunities in process development and supply-chain management

Rick Mullin, 2010 .

ETRNAL VALUES VIA SIX SIGMA: Enthusiasts of the quality methodology risk becoming too inward looking

Rick Mullin, 2003 .

Suven sets the stage for contract research in India

Rick Mullin, 2002 .

Contract Pharma Grows In China

Rick Mullin, 2014 .

U OF MICHIGAN BUYS PFIZER SITE: REPURPOSING: University hopes to re-create jobs lost after R&D center’s closure

Rick Mullin, 2009 .

UPBEAT IN ORLANDO: Software giant SAP racks up kudos at its Sapphire users conference

Rick Mullin, 2006 .

Kiran Mazumdar-Shaw

Rick Mullin, 2013 .

SK spends big on battery separators

Rick Mullin, 2019 .

LILLY ACQUIRES PROTEIN COMPANY: Applied Molecular Evolution will support a biologies push

Rick Mullin, 2003 .

IT survey: Security concerns top the charts

Rick Mullin, 2001 .

Framing the storefront: A tough fit for customer relationship management software

Rick Mullin, 2002 .

LakePharma, Twist form antibody service

Rick Mullin, 2019 .

CRACKING THE TOUGH ONES

Rick Mullin, 2010 .

Flamma expands into the US

Rick Mullin, 2019 .

Takeda taps Schrödinger for drug discovery

Rick Mullin, 2017 .

Lonza to boost highly potent drug actives

Rick Mullin, 2019 .

Kebotix raises funds for R&D automation

Rick Mullin, 2020 .

Calculating a comeback

Rick Mullin, 2005 .

Lanxess launches online marketplace

Rick Mullin, 2019 .

Carlyle buys most of Unchained Labs

Rick Mullin, 2021 .

Evonik, IBM extend digitalization pact

Rick Mullin, 2021 .

Carnegie Mellon partners on a cloud-based laboratory

Rick Mullin, 2021 .

HONEYWELL AT HALFTIME

Rick Mullin, R. Mullin, 1996 .

Reengineering Q & A

Rick Mullin, 1996 .

MANAGING THE OUTSOURCED ENTERPRISE

Rick Mullin, R. Mullin, 1996 .

A NEW COURSE FOR A MAVERICK BUYER

Rick Mullin, 2011 .

Management: Knowledge Management: A Cultural Evolution

Rick Mullin, R. Mullin, 1996 .

Drug Development Costs About $1.7 Billion

Rick Mullin, 2003 .

PLASTICS REVOLUTION IN BIOPROCESSING: With disposable equipment, DRUG AND VACCINE makers are seeing advantages in cost and time to market

Rick Mullin, 2007 .